Login

Financial Snapshot

Revenue
TTM
$204.7M
Gross Margin
TTM
26.73%
Net Income
TTM
-$104.6M
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
590.62%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$369.1M
Cash
2026 Q1
P/E
Last 4 Quarters
N/A
Free Cash Flow
TTM
-$51.87M

Stock Price

Loading...
Market Cap: $1.2496 Billion

About Maravai LifeSciences Holdings Inc

The filing excerpts provided do not contain sufficient substantive content about Maravai LifeSciences Holdings Inc (MRVI) to produce a compliant canonical description. The excerpts consist primarily of SEC form boilerplate, table of contents entries, and forward-looking statement disclaimers. No business description, revenue figures, segment data, product names, customer information, geographic data, or competitive positioning are present in the supplied text. A description cannot be written from these excerpts without importing outside knowledge, which the source-grounding rules prohibit.

Source: SEC 10-K, filed 2026-02-26

Industry: Pharmaceutical Preparations Peers: Azenta Inc Bio Rad Laboratories Inc Bio-Techne Corp Bruker Corp Charles River Laboratories International Inc Syneos Health, Inc. Medpace Holdings Inc Repligen Corp Thermo Fisher Scientific Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support